Company & Sponsor Intelligence

Florida International University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting1

Completed6

Countries1

Therapeutic footprint

adhdintellectual_disability

Indexed studies

NCT01109849Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth
adhd · United StatesPHASE3

NCT05469386Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom
adhd · United StatesPHASE4

NCT03260816Advancing Child Competencies by Extending Supported Services (ACCESS) for Families Program
intellectual_disability · United StatesNA

NCT04636216Open Trial of a Program to Support Parents of Children With Attention-deficit/Hyperactivity Disorder (ADHD)
adhd · United StatesNA

NCT02502799Intervention for Teens With ADHD and Substance Use
adhd · United StatesPHASE3

NCT01127607Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?
adhd · United StatesPHASE4

NCT03511976Adaptive Response to Intervention (RTI) for Students With ADHD
adhd · United StatesPHASE4

NCT06626750Evaluating Stress Management Strategies Within the School Readiness Parenting Program
adhd · United StatesNA

NCT05955274Mobile Behavioral Parent Training for Childhood ADHD: Pilot Trial
adhd · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →